Cargando…

A case–control study to evaluate hematological indices in blood of diabetic and non-diabetic individuals in Ibb City, Yemen

Diabetes mellitus (DM) is a chronic, metabolic illness characterized by an elevation of blood sugar levels. Patients with diabetes show changes in hematological indices. The study aimed to determine hematological indices, ESR, CRP, blood pressure (BP), and weight and their relationship with a fastin...

Descripción completa

Detalles Bibliográficos
Autores principales: Abbas, Abdul Baset, Hazeb, Alia, Al-Badani, Rawan, Al-Thmary, Boshra, Mokaram, Rasha, Al-Najjar, Somayah, Mothna, Shifa, Kssiam, Aziza, Esmail, Abeer, Al-Rashidi, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10550932/
https://www.ncbi.nlm.nih.gov/pubmed/37794107
http://dx.doi.org/10.1038/s41598-023-43973-3
_version_ 1785115654331826176
author Abbas, Abdul Baset
Hazeb, Alia
Al-Badani, Rawan
Al-Thmary, Boshra
Mokaram, Rasha
Al-Najjar, Somayah
Mothna, Shifa
Kssiam, Aziza
Esmail, Abeer
Al-Rashidi, Ali
author_facet Abbas, Abdul Baset
Hazeb, Alia
Al-Badani, Rawan
Al-Thmary, Boshra
Mokaram, Rasha
Al-Najjar, Somayah
Mothna, Shifa
Kssiam, Aziza
Esmail, Abeer
Al-Rashidi, Ali
author_sort Abbas, Abdul Baset
collection PubMed
description Diabetes mellitus (DM) is a chronic, metabolic illness characterized by an elevation of blood sugar levels. Patients with diabetes show changes in hematological indices. The study aimed to determine hematological indices, ESR, CRP, blood pressure (BP), and weight and their relationship with a fasting blood sugar (FBS) level and different variables in diabetic mellitus patients (DM) compared with healthy control (HC). A total of 202 participants (102 DM group and 100 HC group) were selected randomly. Data were collected using a questionnaire. Blood samples were collected from different places and investigated in Zain Medical Laboratories in Ibb City, Yemen (September 2022 to May 2023). GraphPad Prim was used to analyze the results. P-value ≤ 0.05 was considered statistically significant. The mean and standard deviation of age, weight, gender, residence, marital status, education levels, economic status, regular exercise, following a strict diet, and family history of diabetes revealed significant differences between DM and HC groups (P < 0.0001, P = 0001, P = 0.0027, P = 0.0002, P < 0.0001, P < 0.0001, P = 0.0002, P = 0.0011, P < 0.0001 and P = 0.0001, respectively). FBS results, systolic and diastolic BP, MCV, WBCs, monocytes, eosinophils, and platelets displayed significant differences between both groups (P < 0.0001, P < 0.0001 and P = 0.0404, P = 0.0191, P < 0.0001, P = 0.0253, P < 0.0001, and P = 0.0229, respectively). ESR exhibited statistical significance (P < 0.0001), while CRP displayed no significance. A Pearson's correlation showed that weight, Hb, RBCs, PCV, and WBCs were statistically negatively correlated with FBS whereas other hematological indices showed no correlation with FBS. In conclusion, DM patients had relatively higher levels of MCV, WBCs, eosinophils, platelets and ESR than the control group.
format Online
Article
Text
id pubmed-10550932
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-105509322023-10-06 A case–control study to evaluate hematological indices in blood of diabetic and non-diabetic individuals in Ibb City, Yemen Abbas, Abdul Baset Hazeb, Alia Al-Badani, Rawan Al-Thmary, Boshra Mokaram, Rasha Al-Najjar, Somayah Mothna, Shifa Kssiam, Aziza Esmail, Abeer Al-Rashidi, Ali Sci Rep Article Diabetes mellitus (DM) is a chronic, metabolic illness characterized by an elevation of blood sugar levels. Patients with diabetes show changes in hematological indices. The study aimed to determine hematological indices, ESR, CRP, blood pressure (BP), and weight and their relationship with a fasting blood sugar (FBS) level and different variables in diabetic mellitus patients (DM) compared with healthy control (HC). A total of 202 participants (102 DM group and 100 HC group) were selected randomly. Data were collected using a questionnaire. Blood samples were collected from different places and investigated in Zain Medical Laboratories in Ibb City, Yemen (September 2022 to May 2023). GraphPad Prim was used to analyze the results. P-value ≤ 0.05 was considered statistically significant. The mean and standard deviation of age, weight, gender, residence, marital status, education levels, economic status, regular exercise, following a strict diet, and family history of diabetes revealed significant differences between DM and HC groups (P < 0.0001, P = 0001, P = 0.0027, P = 0.0002, P < 0.0001, P < 0.0001, P = 0.0002, P = 0.0011, P < 0.0001 and P = 0.0001, respectively). FBS results, systolic and diastolic BP, MCV, WBCs, monocytes, eosinophils, and platelets displayed significant differences between both groups (P < 0.0001, P < 0.0001 and P = 0.0404, P = 0.0191, P < 0.0001, P = 0.0253, P < 0.0001, and P = 0.0229, respectively). ESR exhibited statistical significance (P < 0.0001), while CRP displayed no significance. A Pearson's correlation showed that weight, Hb, RBCs, PCV, and WBCs were statistically negatively correlated with FBS whereas other hematological indices showed no correlation with FBS. In conclusion, DM patients had relatively higher levels of MCV, WBCs, eosinophils, platelets and ESR than the control group. Nature Publishing Group UK 2023-10-04 /pmc/articles/PMC10550932/ /pubmed/37794107 http://dx.doi.org/10.1038/s41598-023-43973-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Abbas, Abdul Baset
Hazeb, Alia
Al-Badani, Rawan
Al-Thmary, Boshra
Mokaram, Rasha
Al-Najjar, Somayah
Mothna, Shifa
Kssiam, Aziza
Esmail, Abeer
Al-Rashidi, Ali
A case–control study to evaluate hematological indices in blood of diabetic and non-diabetic individuals in Ibb City, Yemen
title A case–control study to evaluate hematological indices in blood of diabetic and non-diabetic individuals in Ibb City, Yemen
title_full A case–control study to evaluate hematological indices in blood of diabetic and non-diabetic individuals in Ibb City, Yemen
title_fullStr A case–control study to evaluate hematological indices in blood of diabetic and non-diabetic individuals in Ibb City, Yemen
title_full_unstemmed A case–control study to evaluate hematological indices in blood of diabetic and non-diabetic individuals in Ibb City, Yemen
title_short A case–control study to evaluate hematological indices in blood of diabetic and non-diabetic individuals in Ibb City, Yemen
title_sort case–control study to evaluate hematological indices in blood of diabetic and non-diabetic individuals in ibb city, yemen
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10550932/
https://www.ncbi.nlm.nih.gov/pubmed/37794107
http://dx.doi.org/10.1038/s41598-023-43973-3
work_keys_str_mv AT abbasabdulbaset acasecontrolstudytoevaluatehematologicalindicesinbloodofdiabeticandnondiabeticindividualsinibbcityyemen
AT hazebalia acasecontrolstudytoevaluatehematologicalindicesinbloodofdiabeticandnondiabeticindividualsinibbcityyemen
AT albadanirawan acasecontrolstudytoevaluatehematologicalindicesinbloodofdiabeticandnondiabeticindividualsinibbcityyemen
AT althmaryboshra acasecontrolstudytoevaluatehematologicalindicesinbloodofdiabeticandnondiabeticindividualsinibbcityyemen
AT mokaramrasha acasecontrolstudytoevaluatehematologicalindicesinbloodofdiabeticandnondiabeticindividualsinibbcityyemen
AT alnajjarsomayah acasecontrolstudytoevaluatehematologicalindicesinbloodofdiabeticandnondiabeticindividualsinibbcityyemen
AT mothnashifa acasecontrolstudytoevaluatehematologicalindicesinbloodofdiabeticandnondiabeticindividualsinibbcityyemen
AT kssiamaziza acasecontrolstudytoevaluatehematologicalindicesinbloodofdiabeticandnondiabeticindividualsinibbcityyemen
AT esmailabeer acasecontrolstudytoevaluatehematologicalindicesinbloodofdiabeticandnondiabeticindividualsinibbcityyemen
AT alrashidiali acasecontrolstudytoevaluatehematologicalindicesinbloodofdiabeticandnondiabeticindividualsinibbcityyemen
AT abbasabdulbaset casecontrolstudytoevaluatehematologicalindicesinbloodofdiabeticandnondiabeticindividualsinibbcityyemen
AT hazebalia casecontrolstudytoevaluatehematologicalindicesinbloodofdiabeticandnondiabeticindividualsinibbcityyemen
AT albadanirawan casecontrolstudytoevaluatehematologicalindicesinbloodofdiabeticandnondiabeticindividualsinibbcityyemen
AT althmaryboshra casecontrolstudytoevaluatehematologicalindicesinbloodofdiabeticandnondiabeticindividualsinibbcityyemen
AT mokaramrasha casecontrolstudytoevaluatehematologicalindicesinbloodofdiabeticandnondiabeticindividualsinibbcityyemen
AT alnajjarsomayah casecontrolstudytoevaluatehematologicalindicesinbloodofdiabeticandnondiabeticindividualsinibbcityyemen
AT mothnashifa casecontrolstudytoevaluatehematologicalindicesinbloodofdiabeticandnondiabeticindividualsinibbcityyemen
AT kssiamaziza casecontrolstudytoevaluatehematologicalindicesinbloodofdiabeticandnondiabeticindividualsinibbcityyemen
AT esmailabeer casecontrolstudytoevaluatehematologicalindicesinbloodofdiabeticandnondiabeticindividualsinibbcityyemen
AT alrashidiali casecontrolstudytoevaluatehematologicalindicesinbloodofdiabeticandnondiabeticindividualsinibbcityyemen